Diazyme Direct HbA1c Assay (Enzymatic, On-Board Lysis), Diazyme Direct HbA1c Assay Calibrator Set, Diazyme Direct HbA1c Assay Control Set

Assay, Glycosylated Hemoglobin

DIAZYME LABORATORIES

The following data is part of a premarket notification filed by Diazyme Laboratories with the FDA for Diazyme Direct Hba1c Assay (enzymatic, On-board Lysis), Diazyme Direct Hba1c Assay Calibrator Set, Diazyme Direct Hba1c Assay Control Set.

Pre-market Notification Details

Device IDK160762
510k NumberK160762
Device Name:Diazyme Direct HbA1c Assay (Enzymatic, On-Board Lysis), Diazyme Direct HbA1c Assay Calibrator Set, Diazyme Direct HbA1c Assay Control Set
ClassificationAssay, Glycosylated Hemoglobin
Applicant DIAZYME LABORATORIES 12889 GREGG COURT Poway,  CA  92064
ContactAbhijit Datta
CorrespondentAbhijit Datta
DIAZYME LABORATORIES 12889 GREGG COURT Poway,  CA  92064
Product CodeLCP  
Subsequent Product CodeJIT
Subsequent Product CodeJJX
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2016-03-21
Decision Date2016-11-21
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00817089021594 K160762 000
00817089021365 K160762 000
00817089021358 K160762 000

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.